Home Applications 206111 Application 206111
Type NDA
Sponsor BOEHRINGER INGELHEIM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 5MG;500MG Yes No 002 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 5MG;1GM Yes No 003 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 12.5MG;500MG Yes No 004 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 12.5MG;1GM Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206111-001 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE 5MG;500MG TABLET / ORAL RLD 2015-08-26 N206111-002 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE 5MG;1GM TABLET / ORAL RLD 2015-08-26 N206111-003 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 N206111-004 SYNJARDY EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26
Orange Book patents# Current patent rows page 1 of 2 · 120 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 8 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206111-001 SYNJARDY 5MG;500MG TABLET / ORAL RLD 2015-08-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206111-002 SYNJARDY 5MG;1GM TABLET / ORAL RLD 2015-08-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206111-003 SYNJARDY 12.5MG;500MG TABLET / ORAL RLD 2015-08-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206111-004 SYNJARDY 12.5MG;1GM TABLET / ORAL RLD, RS 2015-08-26 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 52 · 2,056 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N206111-001 7713938 2027-04-15 Drug substance, Drug product 2015-09-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 7713938*PED 2027-10-15 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 7579449 2028-08-01 Drug substance 2015-09-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 7579449*PED 2029-02-01 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12115179 2030-02-11 U-4023 2024-11-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12115179*PED 2030-08-11 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 10610489 2030-09-30 Drug product 2020-05-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 10610489*PED 2031-03-30 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12527810 2033-04-22 U-4403 2026-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12527810*PED 2033-10-22 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 10258637 2034-04-03 U-2290 2019-04-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 11090323 2034-04-03 U-3193 2021-08-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 11666590 2034-04-03 U-4154 2025-03-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 11813275 2034-04-03 U-3759 2023-12-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 11833166 2034-04-03 U-3776 2024-01-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 11833166 2034-04-03 U-3777 2024-01-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12263153 2034-04-03 U-4154 2025-04-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12427162 2034-04-03 U-4287 2025-10-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12433906 2034-04-03 U-4304 2025-10-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12433906 2034-04-03 U-4293 2025-10-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12433906 2034-04-03 U-4294 2025-10-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12433906 2034-04-03 U-4295 2025-10-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12433906 2034-04-03 U-4296 2025-10-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 9949997 2034-05-17 U-3532 2023-03-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 9949997 2034-05-17 U-3533 2023-03-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 10258637*PED 2034-10-03 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 11090323*PED 2034-10-03 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 11813275*PED 2034-10-03 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 11833166*PED 2034-10-03 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 12433906*PED 2034-10-03 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-001 9949997*PED 2034-11-17 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 7713938 2027-04-15 Drug substance, Drug product 2015-09-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 7713938*PED 2027-10-15 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 7579449 2028-08-01 Drug substance 2015-09-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 7579449*PED 2029-02-01 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 12115179 2030-02-11 U-4023 2024-11-12 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 12115179*PED 2030-08-11 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 10610489 2030-09-30 Drug product 2020-05-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 10610489*PED 2031-03-30 Pediatric extension 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206111-002 12527810 2033-04-22 U-4403 2026-02-10 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 6 · 224 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 20 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0159 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0168 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0175 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0180 Synjardy empagliflozin and metformin hydrochloride Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current